Buprenorfina Molteni

Name: Buprenorfina Molteni Price Comparison: Uses, Dosage, Form & Side Effects
Creator: gmedication.com
Published: 2021-11-01T10:10:10+00:00

Did you experience any side effects after consuming the medication?

Here is the some steps to help you to save money on Buprenorfina Molteni purchase.

Read drug prescription

What is Buprenorfina Molteni
Buprenorfina Molteni side effects
Buprenorfina Molteni dosing

Select the most affordable brand or generic drug
Frequently asked Questions

Who should not take Buprenorfina Molteni?
What other drugs will affect Buprenorfina Molteni?
How should I take Buprenorfina Molteni?

Buprenorfina Molteni reviews

Read drug prescription

What is Buprenorfina Molteni

Buprenorfina Molteni is an opioid medication. An opioid is sometimes called a narcotic.
Buprenorfina Molteni oral is used to treat narcotic addiction. Buprenorfina Molteni sublingual is not for use as a pain medication.
Buprenorfina Molteni may also be used for purposes not listed in Buprenorfina Molteni guide.

Buprenorfina Molteni side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Like other narcotic medicines, Buprenorfina Molteni can slow your breathing. Death may occur if breathing becomes too weak.
Call your doctor at once if you have:

weak or shallow breathing;
a light-headed feeling, like you might pass out;
confusion, unusual thoughts or behavior; or
nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice.

Common side effects may be more likely to occur, such as:

constipation, nausea, vomiting;
headache;
increased sweating;
sleep problems (insomnia); or
pain anywhere in your body.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)

Buprenorfina Molteni dosing

Usual Adult Dose for Opiate Dependence:

Induction dose:
-Day 1: 8 mg sublingually once a day
-Day 2: 16 mg sublingually once a day
Maintenance dose: 4 to 24 mg/day; dose adjustments may be made in increments/decrements of 2 or 4 mg to a level that suppresses opioid withdrawal symptoms and holds the patient in treatment.
Comments:
-To avoid precipitating withdrawal during induction, initiation should occur when clear signs of withdrawal are evident, preferably when moderate objective signs of opioid withdrawal appear.
-Following induction, combination buprenorphine/naloxone is preferred; use of Buprenorfina Molteni alone should be limited to those patients who cannot tolerate naloxone.
Use: For the treatment of opioid dependence, preferably induction only. This drug should be used as part of a complete treatment plan to include counseling and psychosocial support.

Usual Adult Dose for Pain:

Parenteral:
Initial dose: 0.3 mg deep IM or slow IV ; may repeat initial dose once after 30 to 60 minutes if required
Maintenance dose: 0.3 mg deep IM or slow IV at up to 6-hour intervals as needed
Maximum dose: 0.3 mg (IV) or 0.6 mg (IM)
Comments:
-Use extra caution with IV administration, especially the first dose
Use: For the relief of moderate to severe pain

Usual Adult Dose for Chronic Pain:

Individualize dosing taking into account prior analgesic treatment; 7.5 mcg, 10 mcg, 15 mcg, and 20 mcg/hr patches are for opioid-experienced patients only.
-As first opioid analgesic: Initiate with 5 mcg/hr patch applied transdermally every 7 days
Conversion from Other Opioids to Buprenorfina Molteni:
-Discontinue all other around-the-clock opioid drugs when initiating therapy
For patients whose prior total opioid dose is less than 30 mg/day of oral morphine equivalents:
-Initiate with 5 mcg/hr patch applied transdermally every 7 days at next dosing interval
For patients whose prior total opioid dose is between 30 and 80 mg/day of oral morphine equivalents:
-Taper around-the-clock opioids for up to 7 days to no more than 30 mg/day of oral morphine equivalents, then initiate with 10 mcg/hr patch applied transdermally every 7 days starting at the next dosing interval; may use short-acting analgesics as needed until analgesic efficacy is attained.
For patients whose prior total opioid dose is greater than 80 mg/day of oral morphine equivalents:
-Consider use of an alternate analgesic as 20 mcg/hr patch may not provide adequate analgesia
Conversion from Methadone:
-The ratio between methadone and other opioid agonists may vary widely due to its long half-life and accumulation in the plasma; close monitoring is of particular importance.
Titration: Individually titrate to a dose that provides adequate analgesia and minimizes adverse reactions; minimal titration interval is 72 hours
Maximum dose: 20 mcg/hr due to risk of QTc interval prolongation
Comments:
-Monitor patients closely for respiratory depression, especially within 24 to 72 hours after initiating therapy.
-If pain level increases after dose stabilization, attempt to identify source of increased pain before increasing Buprenorfina Molteni dose
-Do not abruptly discontinue; use a gradual downward titration every 7 days, may consider introduction of an immediate-release opioid.
Use: For the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate.

Usual Pediatric Dose for Pain:

Parenteral:
13 years or older:
Initial dose: 0.3 mg deep IM or slow IV ; may repeat initial dose once after 30 to 60 minutes if required
Maintenance dose: 0.3 mg deep IM or slow IV at up to 6-hour intervals as needed
Maximum dose: 0.3 mg
2 to 12 years: 2 to 6 mcg/kg IM or slow IV every 4 to 6 hours; some patients may not need to be remedicated for 6 to 8 hours
Comments:
-Fixed interval or round the clock dosing should not be used until the proper inter-dose interval has been established.
-Use extra caution with IV administration, especially the first dose
Use: For the relief of moderate to severe pain

Usual Pediatric Dose for Opiate Dependence:

Aged 16 years or older:
Induction dose:
-Day 1: 8 mg sublingually once a day
-Day 2: 16 mg sublingually once a day
Maintenance dose: 4 to 24 mg/day; dose adjustments may be made in increments/decrements of 2 or 4 mg to a level that suppresses opioid withdrawal symptoms and holds the patient in treatment.
Comments:
-To avoid precipitating withdrawal during induction, initiation should occur when clear signs of withdrawal are evident, preferably when moderate objective signs of opioid withdrawal appear.
-Following induction, combination buprenorphine/naloxone is preferred; use of Buprenorfina Molteni alone should be limited to those patients who cannot tolerate naloxone.
Use: For the treatment of opioid dependence, preferably induction only. This drug should be used as part of a complete treatment plan to include counseling and psychosocial support.

Active ingredients: Buprenorphine

Select the most affordable brand or generic drug

Strength	Quantity	Price, USD	Country
168 HR BuTrans 0.005 MG/HR Transdermal System
168 HR BuTrans 0.0075 MG/HR Transdermal Patch
168 HR BuTrans 0.015 MG/HR Transdermal System
168 HR Buprenorphine 0.005 MG/HR Transdermal Patch [BuTrans]
168 HR Buprenorphine 0.005 MG/HR Transdermal System [BuTrans]
168 HR Buprenorphine 0.01 MG/HR Transdermal Patch
168 HR Buprenorphine 0.01 MG/HR Transdermal System
168 HR Buprenorphine 0.015 MG/HR Transdermal Patch [BuTrans]
168 HR Buprenorphine 0.015 MG/HR Transdermal System [BuTrans]
Berotam
BuTrans 10 MCG/HR Weekly Transdermal Patch
Buepron
Bunogesic
Bunogesic 0.3mg x 1mL AMP / 1ml		$0.15
Bunogesic 0.3mg x 1mL AMP / 2ml		$0.23
Bupaq
Bupensan
Bupr?norphine Arrow
Bupr?norphine Biogaran
Buprenex (injection - Buprenex)
0 .3mg/ml	10 solution	$115.88	USA
Buprenodale
Buprenorfin Acino
Buprenorfin Evolan
Buprenorfina Actavis
Buprenorfina Azevedos
Buprenorfina Goldfarma
Buprenorfina Sigillata
Buprenorfine
Buprenorfine Fisher
Buprenorfine Mylan
Buprenorphin AWD
Buprenorphin Teva
Buprenorphin dura
Buprenorphin-neuraxpharm
Buprenorphine 1.8 MG/ML Injectable Solution [Simbadol]
Buprenorphine Actavis
Buprenorphine BMM Pharma
Buprenorphine Bluefish
Buprenorphine Hydrochloride Hospira
Buprenorphine Martindale
Buprenorphine Orifarm
Buprenotex
Buprigesic (2 ml)
Buprigesic 0.3mg AMP / 1ml		$0.22
BUPRIGESIC inj 0.3 mg x 2ml		$2.52	Neon Labs
BUPRIGESIC 0.6MG INJECTION 1 vial(s) (2 ML injection each)		$0.46	Neon Laboratories Ltd
Buprénorphine Arrow
Buprénorphine EG
Butrans 10 MCG/HR 7 Day Transdermal System
Butrans 20 MCG/HR 7 Day Transdermal Patch
Butrans 5 MCG/HR 7 Day Transdermal System
Butrans patch
CRAS
Cras 25+1.25 Tablet		$0.06
Cras Capsule/ Tablet / 25mg-1.25mg (10 units)		$0.62	Systopic Laboratories
Feliben
Hapoctasin
Loxina
Morgesic
0 .3mg/1ml	1 ml	$0.20
Nermin
Nopan
Pentorel (2 ml)
0 .3mg/1ml	2 ml	$0.06
0 .3mg/1ml	2 ml	$0.10
Pentorel 0.3mg/ml Injection		$0.05	Khandelwal Laboratories Pvt Ltd
0 .3 mg x 1 mL x 1's		$0.06
Pentorel 0.3mg/ml INJ / 1ml		$0.06
PENTOREL inj 0.3 mg x 1 mL x 1ml		$0.06	Khandelwal
0 .3 mg x 1 mL x 2ml		$0.10
Pentorel 0.3mg/ml INJ / 2ml		$0.10
PENTOREL inj 0.3 mg x 1 mL x 2ml		$0.10	Khandelwal
Prenorvine
Simbadol
Simbadol 1.8 MG/ML Injectable Solution
Subutex
Subutex 2 mg x 7's		$30.80
Subutex 8 mg x 7's		$92.40
TEMGESIC
Temgesic 0.3 mg/1 mL x 1 mL x 5's		$52.13
Temgesic 0.2 mg x 50's		$57.35
Talgesic
0 .3mg/2ml	2 ml	$0.22
Talgesic 0.6 mg Injection		$0.11
Temg?sic
Tidigesic (1 ml)
TIDIGESIC Injection / 0.3mg per ml (1ml units)		$0.16	Sun Pharmaceuticals
TIDIGESIC inj 0.3 mg x 1 mL x 2ml		$0.21	Sun
0 .2 mg x 10's		$0.35
Transtec
Vetergesic
Zalba
buprenorphine (implant)
Subutex 8 mg Sublingual Tabs		$10.20
Buprenorphine 0.3 mg/ml vial		$2.96
Buprenorphine 2 mg tablet sl		$4.14
Buprenex 0.3 mg/ml Solution (1 Box Contains Five 1ml Box)		$46.39
Subutex 2 mg tablet sl		$5.00
Subutex 2 mg Sublingual Tabs		$5.59
Buprenex 0.3 mg/ml ampul		$6.96
Buprenorphine 8 mg tablet sl		$7.74
Subutex 8 mg tablet sl		$9.40
buprenorphine (injection - Sublocade)
Subutex 8 mg Sublingual Tabs		$10.20
Buprenorphine 0.3 mg/ml vial		$2.96
Buprenorphine 2 mg tablet sl		$4.14
Buprenex 0.3 mg/ml Solution (1 Box Contains Five 1ml Box)		$46.39
Subutex 2 mg tablet sl		$5.00
Subutex 2 mg Sublingual Tabs		$5.59
Buprenex 0.3 mg/ml ampul		$6.96
Buprenorphine 8 mg tablet sl		$7.74
Subutex 8 mg tablet sl		$9.40
buprenorphine 1.8 MG/ML (as buprenorphine hydrochloride 1.94 MG/ML) Injectable Solution
buprenorphine 20 MCG/HR Weekly Transdermal Patch
buprenorphine 5 MCG/HR Weekly Transdermal Patch

References

Dailymed."Buprenorphine: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
"Buprenorphine". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
"Buprenorphine". http://www.drugbank.ca/drugs/DB0092... (accessed August 28, 2018).

Buprenorfina Molteni - Frequently asked Questions

Can Buprenorfina Molteni be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Who should not take Buprenorfina Molteni?

You should not use this medicine if you are allergic to Buprenorfina Molteni, or if you have used another narcotic drug within the past 4 hours.

To make sure Buprenorfina Molteni is safe for you, tell your doctor if you have:

any type of breathing problem or lung disease;
curvature of the spine that affects breathing;
liver disease ;
enlarged prostate, urination problems;
problems with your gallbladder, adrenal gland, or thyroid;
a history of head injury, brain tumor, or seizures; or
a history of drug abuse, alcohol addiction, or mental illness.

It is not known whether this medicine will harm an unborn baby. If you use Buprenorfina Molteni while you are pregnant, your baby could become dependent on the drug. This can cause life-threatening withdrawal symptoms in the baby after it is born. Babies born dependent on habit-forming medicine may need medical treatment for several weeks. Tell your doctor if you are pregnant or plan to become pregnant.

Buprenorfina Molteni can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using Buprenorfina Molteni.

Do not give this medication to a child.

What other drugs will affect Buprenorfina Molteni?

Using Buprenorfina Molteni with other drugs that make you sleepy or slow your breathing can cause dangerous or life-threatening side effects. Ask your doctor before using Buprenorfina Molteni with a sleeping pill, a sedative or tranquilizer, other narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures.

Other drugs may interact with Buprenorfina Molteni, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

How should I take Buprenorfina Molteni?

Follow all directions on your prescription label. Buprenorfina Molteni can slow or stop your breathing. Never use Buprenorfina Molteni in larger amounts, or for longer than prescribed. Tell your doctor if the medicine seems to stop working as well in relieving your pain.

Buprenorfina Molteni may be habit-forming, even at regular doses. Never share this medicine with another person, especially someone with a history of drug abuse or addiction. MISUSE OF NARCOTIC MEDICINE CAN CAUSE ADDICTION, OVERDOSE, OR DEATH, especially in a child or other person using the medicine without a prescription. Selling or giving away Buprenorfina Molteni is against the law.

The Buprenorfina Molteni sublingual tablet should be placed under the tongue and allowed to dissolve. Do not chew the tablet or swallow it whole. If your doctor has prescribed more than 2 tablets per dose, place the correct number of tablets under your tongue at the same time and allow them to dissolve completely.

While using Buprenorfina Molteni, you may need frequent blood tests to check your liver function.

If you need surgery, tell the surgeon ahead of time that you are using Buprenorfina Molteni. You may need to stop using the medicine for a short time.

Wear a medical alert tag or carry an ID card stating that you take Buprenorfina Molteni. Any medical care provider who treats you should know that you are being treated for narcotic addiction. Make sure your family members know you are using Buprenorfina Molteni in case they need to speak for you during an emergency.

Do not stop using Buprenorfina Molteni suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to safely stop using Buprenorfina Molteni.

Store at room temperature away from moisture and heat.

Keep track of the amount of medicine used from each new bottle. Buprenorfina Molteni is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription.

Do not keep leftover Buprenorfina Molteni pills. Ask your pharmacist where to locate a drug take-back disposal program. If there is no take-back program, flush any unused pills down the toilet

Never crush or break a Buprenorfina Molteni pill to inhale the powder or mix it into a liquid to inject the drug into your vein. This practice has resulted in death with the misuse of Buprenorfina Molteni and similar prescription drugs.

Can Buprenorfina Molteni be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Buprenorfina Molteni be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

Reviews

Following the study conducted by gmedication.com on Buprenorfina Molteni, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Buprenorfina Molteni. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.